Carson Wealth (CWM LLC)’s Astria Therapeutics ATXS Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-199	Closed	-$3K	–	5678
2025 Q4	$3K	Buy	199 +7	+4%	+$84	﹤0.01%	4948
2025 Q3	$1K	Buy	192 +40	+26%	+$271	﹤0.01%	5077
2025 Q2	$1K	Buy	152 +102	+204%	+$494	﹤0.01%	4966
2025 Q1	$0	Sell	50 -17	-25%	-$119	﹤0.01%	5047
2024 Q4	$1K	Buy	67 +2	+3%	+$21	﹤0.01%	4655
2024 Q3	$1K	Buy	65 +9	+16%	+$100	﹤0.01%	4509
2024 Q2	$1K	Buy	56 +8	+17%	+$78	﹤0.01%	4307
2024 Q1	$1K	Hold	48	–	–	﹤0.01%	4072
2023 Q4	$0	Buy	+48	New	+$265	﹤0.01%	4124

Carson Wealth (CWM LLC)'s ATXS Position: Q1 2026 in Review

Carson Wealth (CWM LLC) sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 199 shares — an estimated $3K sold.

Carson Wealth (CWM LLC) first reported a position in ATXS in Q4 2023 and held it in 9 quarters. The position peaked at $3K in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Carson Wealth (CWM LLC) reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 199 Astria Therapeutics shares in Q1 2026, an estimated $3K.
Carson Wealth (CWM LLC) first reported a position in Astria Therapeutics in Q4 2023 and held it in 9 quarters.
Carson Wealth (CWM LLC)'s Astria Therapeutics position peaked at $3K in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.